Literature DB >> 17152026

Excess length of stay attributable to surgical site infection following hip replacement: a nested case-control study.

Vicente Monge Jodra1, Lourdes Sainz de Los Terreros Soler, Cristina Diaz-Agero Perez, Carmen Maria Saa Requejo, Nieves Plana Farras.   

Abstract

OBJECTIVE: We estimated the impact of hip replacement-associated surgical site infection (SSI) on morbidity and length of stay.
METHODS: This was a pairwise matched (1 : 1) case-control study nested in a cohort. All patients who underwent hip replacement from January 1, 2000, to June 30, 2004, were prospectively enrolled for the nested case-control design analysis and were monitored from the time of surgery until hospital discharge, including any patients readmitted because of infection.
RESULTS: Among the 1,260 hip replacements performed, 28 SSIs were detected, yielding a crude SSI rate of 2.2%. The median excess length of stay attributable to SSI was 32.5 days (P<.001), whereas the median prolonged postoperative stay due to SSI was 31 days (P<.001). Deep-wound SSI was the type that prolonged hospital stay the most (up to 49 days). Of the patients who developed an SSI, 4 required revision surgery, for an SSI-related morbidity rate of 14.3%.
CONCLUSION: SSI prolongs hospital stay; however, although hospital stay is a rough indicator of the cost of this complication, to accurately estimate the costs of SSI, we would need to consider individual costs in a linear regression model adjusted for all possible confounding factors.

Entities:  

Mesh:

Year:  2006        PMID: 17152026     DOI: 10.1086/509828

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  10 in total

Review 1.  Surgical site infections--economic consequences for the health care system.

Authors:  Karolin Graf; Ella Ott; Ralf-Peter Vonberg; Christian Kuehn; Tobias Schilling; Axel Haverich; Iris Freya Chaberny
Journal:  Langenbecks Arch Surg       Date:  2011-03-15       Impact factor: 3.445

2.  Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.

Authors:  Aaron C Miller; Linnea A Polgreen; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-09       Impact factor: 3.254

3.  Reducing surgical site infections in hepatopancreatobiliary surgery.

Authors:  Eugene P Ceppa; Henry A Pitt; Michael G House; E Molly Kilbane; Attila Nakeeb; C Max Schmidt; Nicholas J Zyromski; Keith D Lillemoe
Journal:  HPB (Oxford)       Date:  2012-11-05       Impact factor: 3.647

4.  No infection reduction using chlorhexidine wipes in total joint arthroplasty.

Authors:  Nicholas J Farber; Antonia F Chen; Sarah M Bartsch; Jody L Feigel; Brian A Klatt
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

5.  Prospective study on antimicrobial prophylaxis in total hip arthroplasty.

Authors:  Takahito Yuasa; Jun Yamakawa; Katsuhiko Maezawa; Kazuo Kaneko
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-09-21

6.  Surgical site infection in orthopedic trauma: A case-control study evaluating risk factors and cost.

Authors:  Rachel V Thakore; Sarah E Greenberg; Hanyuan Shi; Alexandra M Foxx; Elvis L Francois; Marc A Prablek; Samuel K Nwosu; Kristin R Archer; Jesse M Ehrenfeld; William T Obremskey; Manish K Sethi
Journal:  J Clin Orthop Trauma       Date:  2015-06-18

7.  Economical analysis on prophylaxis, diagnosis, and treatment of periprosthetic infections.

Authors:  Mariano Fernandez-Fairen; Ana Torres; Ann Menzie; Daniel Hernandez-Vaquero; José Manuel Fernandez-Carreira; Antonio Murcia-Mazon; Enrique Guerado; Luis Merzthal
Journal:  Open Orthop J       Date:  2013-06-14

8.  Improving public reporting and data validation for complex surgical site infections after coronary artery bypass graft surgery and hip arthroplasty.

Authors:  Michael S Calderwood; Ken Kleinman; Michael V Murphy; Richard Platt; Susan S Huang
Journal:  Open Forum Infect Dis       Date:  2014-12-11       Impact factor: 3.835

Review 9.  Health care-associated infections - an overview.

Authors:  Mainul Haque; Massimo Sartelli; Judy McKimm; Muhamad Abu Bakar
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

10.  Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.

Authors:  Mary L Townsend; Melanie W Pound; Richard H Drew
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.